#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Refer to report.
See Compliance Statement B: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
This test detects mutations in EGFR exons 18, 19, 20 and 21.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
88381, 81235, G0452
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
ERBB1 (EGFR Mutation Detection by Pyrosequencing), Erlotinib Responsiveness in NSCLC (EGFR Mutation Detection by Pyrosequencing), Gefitinib Responsiveness in NSCLC (EGFR Mutation Detection by Pyrosequencing), IRESSA Responsiveness in NSCLC (EGFR Mutation Detection by Pyrosequencing), Non-small Cell Lung Cancer (NSCLC) Therapeutic Panel: EGFR Mutation Analysis and ALK FISH Analysis, Non-small Cell Lung Cancer (NSCLC) Therapeutic Panel: EGFR Mutation Analysis and ALK FISH Analysis (EGFR Mutation Detection by PCR and Fragment Analysis)
, NSCLC or Non Small-Cell Lung Cancer (EGFR Mutation Detection by PCR and Fragment Analysis), Tarceva Responsiveness in NSCLC (EGFR Mutation Detection by PCR and Fragment Analysis) |
*ExistCrossReferences>
|